Astute Medical Overview
- Year Founded
-
2007
- Status
-
Acquired/Merged
- Employees
-
46
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$90M
Astute Medical General Information
Description
Developer of biomarkers intended for acute medical conditions and diseases. The company's biomarkers can serve as the basis for novel diagnostic tests for abdominal pain, cerebrovascular injury, acute coronary syndromes, kidney injury and sepsis, helping clinicians improve patient outcomes.
Contact Information
Website
www.astutemedical.comCorporate Office
- 3550 General Atomics Court Building
- 02/620
- San Diego, CA 92121
- United States
Corporate Office
- 3550 General Atomics Court Building
- 02/620
- San Diego, CA 92121
- United States
Astute Medical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Merger/Acquisition | 04-Apr-2018 | $90M | Completed | Generating Revenue | ||
| 8. Later Stage VC (Series F) | 14-Dec-2016 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series E) | 14-Oct-2015 | Completed | Generating Revenue | |||
| 6. Debt - General | 09-Oct-2014 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series D) | 29-Jul-2014 | Completed | Generating Revenue | |||
| 4. Debt - General | 21-Dec-2012 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series C) | 07-Jun-2012 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 08-Mar-2011 | $39.7M | $46M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 01-May-2008 | $6.37M | $6.37M | Completed | Product Development |
Astute Medical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series F | ||||||||
| Series E | ||||||||
| Series D | ||||||||
| Series C | ||||||||
| Series B | 12,264,196 | $0.000100 | 8% | $3.23 | $3.23 | 1x | $3.23 | 22.01% |
| Series A | 2,068,182 | $0.000100 | 8% | $3.08 | $3.08 | 1x | $3.08 | 3.71% |
Astute Medical Comparisons
Industry
Financing
Details
Astute Medical Competitors (6)
One of Astute Medical’s 6 competitors is Akonni Biosystems, a Venture Capital-Backed company based in Frederick, MD.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Akonni Biosystems | Venture Capital-Backed | Frederick, MD | ||||
| Meridian Bioscience | Private Equity-Backed | Cincinnati, OH | ||||
| Decipher Urologic Cancers | Formerly VC-backed | San Diego, CA | ||||
| Genomind | Venture Capital-Backed | King of Prussia, PA | ||||
| Boston Scientific | Corporation | Marlborough, MA |
Astute Medical Patents
Astute Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023229375-A1 | Methods and compositions for assessing and treating persistent acute kidney injury based on c-c motif chemokine ligand 14 measurement | Pending | 03-Mar-2022 | ||
| EP-4487114-A1 | Methods and compositions for assessing and treating persistent acute kidney injury based on c-c motif chemokine ligand 14 measurement | Pending | 03-Mar-2022 | ||
| EP-4487114-A4 | Methods and compositions for assessing and treating persistent acute kidney injury based on c-c motif chemokine ligand 14 measurement | Pending | 03-Mar-2022 | ||
| WO-2023168299-A1 | Methods and compositions for assessing and treating persistent acute kidney injury based on c-c motif chemokine ligand 14 measurement | Inactive | 03-Mar-2022 | ||
| AU-2021381364-A1 | Methods and compositions for treatment of renal injury and renal failure | Pending | 18-Nov-2020 | A61K35/14 |
Astute Medical Signals
Astute Medical Former Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bio-Techne | Corporation | Minority | ||
| CRG | Lender/Debt Provider | Minority | ||
| De Novo Ventures | Venture Capital | Minority | ||
| Delphi Ventures (California) | Venture Capital | Minority | ||
| Domain Associates | Venture Capital | Minority |
Astute Medical FAQs
-
When was Astute Medical founded?
Astute Medical was founded in 2007.
-
Where is Astute Medical headquartered?
Astute Medical is headquartered in San Diego, CA.
-
What is the size of Astute Medical?
Astute Medical has 46 total employees.
-
What industry is Astute Medical in?
Astute Medical’s primary industry is Biotechnology.
-
Is Astute Medical a private or public company?
Astute Medical is a Private company.
-
What is the current valuation of Astute Medical?
The current valuation of Astute Medical is .
-
What is Astute Medical’s current revenue?
The current revenue for Astute Medical is .
-
How much funding has Astute Medical raised over time?
Astute Medical has raised $200M.
-
Who are Astute Medical’s investors?
Bio-Techne, CRG, De Novo Ventures, Delphi Ventures (California), and Domain Associates are 5 of 10 investors who have invested in Astute Medical.
-
Who are Astute Medical’s competitors?
Akonni Biosystems, Meridian Bioscience, Decipher Urologic Cancers, Genomind, and Boston Scientific are some of the 6 competitors of Astute Medical.
-
When was Astute Medical acquired?
Astute Medical was acquired on 04-Apr-2018.
-
Who acquired Astute Medical?
Astute Medical was acquired by BioMérieux.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process